New Key Statistics Module, Z-Score and F-Score
NAS:CCLD Key Ratios
| Market Cap $ M | 89.66 |
| Enterprise Value $ M | 130.28 |
| P/E(ttm) | 35.17 |
| PE Ratio without NRI | 6.81 |
| Forward PE Ratio | 4.95 |
| Price/Book | 5.15 |
| Price/Sales | 0.71 |
| Price/Free Cash Flow | 4.59 |
| Price/Owner Earnings | 5.21 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 128.00 |
| EPS (TTM) $ | 0.06 |
| Beneish M-Score | -4.12 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -52.00 |
| EV-to-EBIT | 14.01 |
| EV-to-EBITDA | 4.78 |
| PEG | -- |
| Shares Outstanding M | 42.49 |
| Net Margin (%) | 6.21 |
| Operating Margin % | 7.18 |
| Pre-tax Margin (%) | 6.42 |
| Quick Ratio | 1.01 |
| Current Ratio | 1.02 |
| ROA % (ttm) | 9.21 |
| ROE % (ttm) | 16.04 |
| ROIC % (ttm) | 12.63 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.63 |
CCLD Number of Guru Trades
CCLD Volume of Guru Trades
Gurus Latest Trades with NAS:CCLD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CCLD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CareCloud Inc Insider Transactions
No Available Data
Guru Commentaries on NAS:CCLD
Bilbel Capital
Bearish
2026 Q3
pdf
What the manager wrote
We think CareCloud is undervalued. But we found companies that are more undervalued. So we sold most of our CareCloud shares to buy them. CareCloud’s value mainly depends on how many customers it keeps, and how AI will impact their profits. AI can hurt companies like CareCloud in 3 ways: higher customer-acquisition costs, lower prices or customer losses, and lower client revenue. If AI makes switching cheaper, customers can seek lower prices. CareCloud can benefit either way, but the potential for significant profit reduction exists if major advances in technology and changes in regulation occur.
News about NAS:CCLD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers